Covestor’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40K Buy
928
+414
+81% +$22.5K 0.02% 906
2026
Q1
$32K Sell
514
-68
-12% -$5.44K 0.02% 930
2025
Q4
$56K Buy
582
+71
+14% +$6.96K 0.03% 865
2025
Q3
$50K Sell
511
-31
-6% -$3.21K 0.03% 903
2025
Q2
$58K Buy
542
+12
+2% +$1.21K 0.03% 833
2025
Q1
$54K Sell
530
-299
-36% -$30.1K 0.04% 813
2024
Q4
$74K Buy
829
+73
+10% +$6.43K 0.05% 680
2024
Q3
$63K Sell
756
-218
-22% -$17.2K 0.04% 775
2024
Q2
$75K Sell
974
-253
-21% -$18.5K 0.05% 662
2024
Q1
$84K Buy
1,227
+611
+99% +$39.3K 0.05% 635
2023
Q4
$36K Sell
616
-9
-1% -$480 0.02% 979
2023
Q3
$33K Sell
625
-26
-4% -$1.36K 0.02% 934
2023
Q2
$35K Sell
651
-23
-3% -$1.2K 0.03% 925
2023
Q1
$34K Buy
674
+4
+0.6% +$189 0.03% 852
2022
Q4
$31K Sell
670
-458
-41% -$19.8K 0.03% 899
2022
Q3
$44K Sell
1,128
-6,032
-84% -$242K 0.04% 735
2022
Q2
$266K Buy
7,160
+3,877
+118% +$158K 0.21% 63
2022
Q1
$145K Buy
3,283
+1,494
+84% +$64.7K 0.1% 288
2021
Q4
$76K Buy
+1,789
New +$75.2K 0.11% 295

Other funds holding BSX

Covestor's BSX Position: Q2 2026 in Review

Covestor increased its Boston Scientific (BSX) stake by 81% in Q2 2026, buying an estimated $22.5K and bringing the position to 928 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #906.

Covestor first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $266K in Q2 2022. 932 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Covestor held 928 shares of Boston Scientific worth $40K as of Q2 2026.
  • Covestor bought 414 Boston Scientific shares in Q2 2026, an estimated $22.5K.
  • Boston Scientific made up 0.02% of Covestor's portfolio in Q2 2026, its #906 holding.
  • Covestor first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Boston Scientific position peaked at $266K in Q2 2022.
  • 932 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.